<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

3 min read

Stroke Care During an Evolving Pandemic: An Interview with J Mocco, MD

By Anne Staylor on 7/30/20 11:29 AM

J Mocco, MD, MS discusses how an evolving pandemic is affecting stroke care in an interview with SmartTRAK

The COVID-19 pandemic has dramatically disrupted health care around the world and is wreaking havoc on medical device markets. In the US, social distancing and other mitigation efforts have helped flatten the curve and many states are now working toward reopening their economies.

The pandemic continues to evolve and its impact on healthcare delivery systems is rapidly changing. Elective surgery has re-started again in many states and hard-hit places like New York City have seen COVID-19 cases peak and start to trend downward. So how are these trends affecting stroke care? Why are strokes up in some regions but down in others? When will neurointerventional procedure volumes return to pre-COVID levels? To find out the answers to these questions and more, SmartTRAK talked with J Mocco, MD, MS, Vice Chair, Department of Neurosurgery and Professor of Neurosurgery at Mount Sinai Health System in New York City.

To listen to the interview recorded via Uberconference on Monday May 11, click on the following video. A transcript of the interview can be downloaded here.

Continue Reading
7 min read

COVID-19 Slows SCS Market Momentum: Q120 Market Recap

By Anne Staylor on 6/30/20 11:00 AM

The SCS market saw double-digit declines in Q120 as elective procedures fell off a cliff toward the end of the quarter due to COVID-19

After a disappointing slowdown in 2019, the spinal cord stimulation (SCS) market was positioned for growth in Q120 after a successful North American Neuromodulation Society (NANS) Annual Meeting in January 2020. With new data and products providing an early tailwind for all SCS competitors, companies reported positive momentum until approximately the third week of March when COVID-19 led to shelter-in-place orders and a sharp decline in elective procedures. This effectively put a halt to the vast majority of SCS trials and implants in the US and also impacted companies with SCS sales in China during January and February ...

Among the many topics covered in the comprehensive Q120 Spinal Cord Stimulation (SCS) Market Recap* are:

Continue Reading
6 min read

The Week in Neuromodulation: New Clinical Trials and Devices

By Thomas Wallick on 6/23/20 8:30 AM

This week, our expert analysts have sifted through the noise to present some of the latest product developments and clinical trials from the Neuromodulation industry. At SmartTRAK,  our analysts constantly monitor the worldwide MedTech industry to present real-time news, analysis and financial data. All of our analysts are experts in their field, having worked in business development, marketing and competitive intelligence roles at leading medical device companies.

The following is a small sampling of Neuromodulation segment updates from the past week that were compiled, reviewed and posted throughout the day by the industry-experienced analysts at SmartTRAK:

Mainstay Medical Receives FDA Approval for ReActiv8 System

Mainstay Medical rec’d FDA approval 6/16/20 for the ReActiv8 System indicated for stimulation of the L2 medial branch of the dorsal ramus for intractable CLBP assoc. w/ multifidus muscle dysfunction. Chris Gilligan, MD-INS Webinar: Novel Stimulation Technologies-Recent Research.

Non-Invasive VNS for PTSD and Mild TBI

The VA is sponsoring a 100-pt, double-blinded study evaluating the effect of non-invasive VNS (nVNS) vs sham on memory and symptoms of PTSD and mild TBI (mTBI) as well as brain and physiology in veterans w/ mTBI and PTSD. The study starts 8/1/2020. clinicaltrials.gov

Rice-Sized Neural Stimulator for DBS

Rice University researchers demonstrated that a miniature, wireless magnetically powered neural stimulator (> 100 Hz) can provide DBS in a rodent model for Parkinson’s disease and that these devices can be miniaturized to millimeter-scale and fully implanted. Neuron

Continue Reading
4 min read

Q419/FY19 Market Recap: Innovation Amid Weakness in SCS

By Anne Staylor on 4/23/20 9:30 AM

Although the Spinal Cord Stimulation (SCS) Market was down YoY in Q419 and FY19, new data and devices are on deck for 2020

Continue Reading
6 min read

A Critical Crossroads for COVID-19: An Interview with Krishnan Chakravarthy

By Anne Staylor on 3/23/20 6:06 PM

Krishnan Chakravarthy, MD, PhD discusses the state of the pandemic and its impact on pain medicine in an interview with SmartTRAK

Krishnan Chakravarthy, MD, PhD discusses the COVID-19 pandemic, current and evolving methods for containing and treating the virus, how it's changing the practice of pain medicine and its impact on industry in an interview with SmartTRAK. Dr. Chakravarthy is Chairman of the COVID-19 Task Force for the American Society of Pain and Neuroscience (ASPN), a virologist, pain management specialist and assistant professor of anesthesiology at the University of California, San Diego (UCSD). 

To find out more, including lessons learned from the 1918 Spanish flu pandemic, click on the following video to listen to the interview conducted by Anne Staylor, SmartTRAK's Managing Editor and Director of Advanced Technologies, recorded live via Uberconference (47:29 minutes).  Specific interview topics by time code are also outlined below, as is a link to download the transcript.

Continue Reading
5 min read

Medtronic Ups its Game with Percept DBS and BrainSense Technology

By Anne Staylor on 3/13/20 9:30 AM

Mike Daly, VP and GM of Medtronic’s Brain Modulation, discusses the Company’s new Percept DBS System with BrainSense Technology in an interview with SmartTRAK

Although Medtronic has lost share in deep brain stimulation (DBS) over the last several years, the Company upped its game recently with the EU launch of its new Percept PC Neurostimulator with BrainSense technology, which received CE Mark in January 2020. Percept is a primary cell DBS device that can send and record brain signals while delivering therapy to patients for the treatment of symptoms associated with Parkinson’s disease, essential tremor, primary dystonic, epilepsy and obsessive-compulsive disorder.  Although Percept is currently available in the EU for open-loop sensing, the device is closed-loop capable, and Medtronic plans to conduct additional research in closed-loop DBS in hopes of eventually gaining regulatory approval for an Adaptive DBS system. 

To find out more about Percept DBS, BrainSense technology and what’s next for Medtronic’s Brain Modulation Business, click on the following video to listen to SmartTRAK’s interview with Mike Daly, Vice President and General Manager of the Brain Modulation Business within Medtronic. A transcript of the interview is also provided below.

Continue Reading
3 min read

SmartTRAK Seeking an Enterprise Sales Executive

By Sharon O'Reilly on 3/2/20 4:45 PM

Location: Northeast US near the Boston Area

Full-time Position

Position:

Are you a proven hunter with a successful track record in medical device or healthcare enterprise sales? Are you looking for flexibility beyond your four office walls? Would you thrive in an entrepreneurial environment? If so, we’d like to talk to you. We’re BioMedGPS the creators of SmartTRAK, the leading strategic advisory and healthcare analytics provider in the life sciences industry. Our team is expanding and seeking a Enterprise Sales Executive who can grow with us. The Enterprise Sales Executive will be responsible for selling SmartTRAK’s suite of business intelligence solutions to C- suite and other senior level executives in major medical device companies, as well as building long term strategic programs and relationships at all levels of the enterprise.

About SmartTRAK
SmartTRAK is the first real-time business intelligence portal used by major orthopedic, wound, regenerative medicine and neuro therapies companies. We are driven by data but fueled by insights. Curated by industry experts, our up-to-date data, analytics and competitive intelligence help medical device executives make more informed strategic business decisions.

Learn More and Apply

Continue Reading
4 min read

SmartTRAK's Anne Staylor at the International Stroke Conference 2020

By Lindsey Wolejko on 2/17/20 11:02 PM

Anne Staylor, SmartTRAK's Managing Editor and Director of Advanced Technologies, will be attending the International Stroke Conference 2020, to be held at the Los Angeles Convention Center, Feb 19-21.

The theme for the conference is A New Era for Stroke Science and Brain Health. According to their website "The International Stroke Conference is the world’s premier meeting dedicated to the science and treatment of cerebrovascular disease. This 2½-day conference features more than 1,700 compelling presentations in 21 categories that emphasize basic, clinical and translational sciences and provides the opportunity to network with thousands of colleagues in the stroke field from around the world with wide-ranging expertise and experience."

Continue Reading
1 min read

NANS StartUp Spotlight: Micro-Leads Medical

By Lindsey Wolejko on 2/7/20 9:38 AM

Micro-Leads Medical, based in Somerville, MA, showcased HD64, an emerging, high-resolution spinal cord stimulation therapy for treating chronic focal pains of the low-back, trunk, extremities and feet at NANS 2020. Anne Staylor, SmartTRAK's Managing Editor and Sr. Director of Advanced Technologies, attended the NANS 2020 Emerging Technologies Forum and saw this novel technology designed for the spinal cord stimulation market.

Continue Reading
3 min read

SmartTRAK's Anne Staylor at NANS 2020 in Las Vegas

By Lindsey Wolejko on 1/27/20 9:00 AM

Anne Staylor, SmartTRAK's Managing Editor and Director of Advanced Technologies, is in Las Vegas attending NANS 2020, the North American Neurological Society's  23rd annual meeting, and, as you can see from the photo above taken at NANS, she is already thinking about NANS 2021 in Orlando. The theme of the this year's NANS is “Driving Innovation Through Science and Evidence.”  Anne, who covers Neuromodulation for SmartTRAK, will be reporting on the meeting through articles and interviews...

Continue Reading

    Recent Articles